LinkedIn Google+ Twitter Facebook

Open Letter to Boston Business Journal

Caris Life Sciences® Chairman and CEO, David D. Halbert, pens an open letter to the Boston Business Journal on why cancer patients deserve accurate information about tumor profiling.

Learn More

Caris Life Sciences

Fulfilling the promise of personalized medicine through advanced laboratory testing, including tumor profiling and innovative blood-based cancer diagnostics.


Individualizing cancer treatment

Providing the clinically relevant information oncologists need to individualize cancer treatment with advanced cancer biomarker testing.


Blood-based cancer detection

A revolution in blood-based diagnostics through identification and characterization of disease-associated circulating microvesicles (cMVs).

Physician Resources

Read the latest research about Caris Molecular Intelligence Service and Carisome and access reports, billing information and forms through our convenient online resources.

Portal Access

Conveniently access MI Profile reports for Molecular Intelligence orders or enter case data in the Registry Portal.

Patient Resources

Caris Life Sciences is committed to supporting oncologists and their patients through educational initiatives and easy-to-use online resources.